<DOC>
	<DOCNO>NCT00251355</DOCNO>
	<brief_summary>The purpose study test new treatment pancreatic cancer remove surgery . This treatment Phase I dose escalation research study combine one drug increase dos fix dose second drug radiation therapy . The drug use increase dos gemcitabine whereas 5-fluorouracil remain patient .</brief_summary>
	<brief_title>Gemcitabine , 5-Fluorouracil , Radiation Therapy Treatment Non-Metastatic Pancreatic Cancer</brief_title>
	<detailed_description>- Ultimately plan find maximum tolerate dose combination gemcitabine , 5-fluorouracil radiation therapy . We also hope assess number people respond therapy assess feasibility give intraoperative radiation therapy follow gemcitabine , 5-fluorouracil , external beam radiation therapy . - A surgical procedure , either laparotomy laparoscopy , require check amount disease treatment start . - All patient receive two chemotherapy drug radiation therapy . Both gemcitabine 5-fluorouracil begin first week radiation therapy . 5-fluorouracil give continuously intravenous infusion continue external beam radiation therapy complete . The gemcitabine give ( different dos cohort patient ) per week seven week . Radiation therapy give daily five day seven week . On day gemcitabine give , radiation therapy give approximately four hour gemcitabine dose . - Four week complete radiation therapy chemotherapy , patient undergo scan check extent disease . Following scan , patient consider repeat surgical procedure remove tumor , possible . If removal tumor possible , patient receive intraoperative radiation therapy . - After complete therapy , patient see least every 3 month one year . A complete physical exam CT scan do regularly .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>Histologic confirmation locally unresectable pancreatic adenocarcinoma . Patients either measurable evaluable disease eligible . Unresectable , nonmetastatic tumor . Unresectable patient include local extension tumor adjacent structure and/or nodal metastasis . Total bilirubin &lt; 2.0 mg/dl AST &lt; 3x ULN Serum creatinine &lt; 2.0 mg/dl WBC &gt; 3,000/mm3 Platelets &gt; 100,000/mm3 ECOG performance status &lt; = 2 Life expectancy great 12 week Evidence peritoneal seed malignancy Prior radiation therapy chemotherapy pancreatic cancer Myocardial infarction past 6 month Major surgery past two week Uncontrolled serious medical psychiatric illness Pregnant lactate woman Concurrent malignancy site , except limited basal cell carcinoma squamous cell carcinoma skin carcinoma situ cervix .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>72 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>gemcitabine</keyword>
	<keyword>5-fluorouracil</keyword>
	<keyword>5-FU</keyword>
	<keyword>unresectable pancreatic cancer</keyword>
	<keyword>non-metastatic pancreatic cancer</keyword>
</DOC>